Celanese EVA Performance Polymers, PSI partner to develop drug-eluting devices Particle Sciences Inc. , a respected pharmaceutical CRO, and Celanese EVA Overall performance Polymers, a leading provider of ethylene vinyl acetate into pharmaceutical applications, will work together to streamline the advancement of drug-eluting devices.’ With this collaboration, there is a highly streamlined process by which Particle Sciences obtains access to make use of Celanese EVA polymers in early development efforts.’ Robert Lee, Vice President Pharmaceutical Advancement at Particle Sciences provides, ‘Combination products have unique development challenges.’..Of these affected, 22 people have died to time. At the invitation of and in conjunction with the National Health insurance and Family Preparation Commission of China, a team of WHO experts has recently arrived in the country and are investigating possible sources of infection, and the best ways to prevent and control the disease. Related StoriesEnsemble versions provide accurate real-period estimates of current and impending flu activityNew studies raise important queries about effect of statin therapy on performance of flu vaccinesFlu vaccine considerably reduces stroke riskAt a media briefing on 19th April, WHO Representative in China Michael O’Leary commented: The mission is merely getting underway so there are not yet findings to survey.